February 19, 2020

Avoid Routine Corticosteroids
in Treatment of Suspected
Coronavirus Infection

Whether in a hospital or community setting, pharmacists are likely sometime this year to encounter patients diagnosed with fast-spreading coronavirus. That’s why awareness of clinical treatment recommendations are so important. Find out why the World Health Organization is recommending against the use of corticosteroids in this acute respiratory illness unless indicated for another condition.


Don’t Assume GI Bleeding in Atrial Fibrillation Patients
Is Always Drug-Related

Gastrointestinal bleeding is an issue that affects a small percentage of atrial fibrillation (AFib) patients on blood thinners. A new study warns against assuming that is the only cause, however. Find out what percentage of AFib patients with GI bleeding ended up being diagnosed with colorectal cancer.

Meta-Analysis Determines Best Treatment Options for Severe Psoriasis

While treatment options for moderate-to-severe psoriasis have exploded, greatly benefitting patients, the availability of novel biologics and oral treatments has also increased the complexity of treatment. Now, researchers have conducted meta-analyses to offer specific advice for use of the agents in both the short- and long-term. Here are the details.


Nitrosamine Levels at Acceptable Levels in U.S. Metformin;
No Recalls Ordered

Any recalls of the common type 2 diabetes drug metformin would cause disruption for millions of patients. Pharmacists are unlikely to have to deal with that crisis in the immediate future, however, because the FDA found that potentially carcinogenic NDMA levels do not exceed the acceptable daily intake for patients. Here is more information.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -